BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 7856623)

  • 1. Clozapine therapy for Parkinson's disease and other movement disorders.
    Pfeiffer C; Wagner ML
    Am J Hosp Pharm; 1994 Dec; 51(24):3047-53. PubMed ID: 7856623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging role of clozapine in the treatment of movement disorders.
    Factor SA; Friedman JH
    Mov Disord; 1997 Jul; 12(4):483-96. PubMed ID: 9251065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine treatment of psychosis in Parkinson's disease: a report of five consecutive cases.
    Wolk SI; Douglas CJ
    J Clin Psychiatry; 1992 Oct; 53(10):373-6. PubMed ID: 1358876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experience.
    Trosch RM; Friedman JH; Lannon MC; Pahwa R; Smith D; Seeberger LC; O'Brien CF; LeWitt PA; Koller WC
    Mov Disord; 1998 May; 13(3):377-82. PubMed ID: 9613725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
    Prescrire Int; 2002 Feb; 11(57):1-6. PubMed ID: 11985366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The trial use of clozapine for abnormal involuntary movement disorders.
    Caine ED; Polinsky RJ; Kartzinel R; Ebert MH
    Am J Psychiatry; 1979 Mar; 136(3):317-20. PubMed ID: 154301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clozapine in treatment of neuropsychiatric diseases in the elderly].
    Retz W; Rösler M; Sitzmann L; Becker T
    Fortschr Neurol Psychiatr; 1997 Aug; 65(8):347-53. PubMed ID: 9378447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of clozapine in neurologic disorders.
    Safferman AZ; Kane JM; Aronowitz JS; Gordon MF; Pollack S; Lieberman JA
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():98-101. PubMed ID: 7961585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroconvulsive therapy in Parkinson's disease and other movement disorders.
    Faber R; Trimble MR
    Mov Disord; 1991; 6(4):293-303. PubMed ID: 1758447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
    Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Parkinson's disease. Psychological disorders: striking a balance in order to optimise antiparkinsonian treatment.
    Prescrire Int; 2011 Oct; 20(120):242-5. PubMed ID: 21970092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes.
    Rich SS; Friedman JH; Ott BR
    J Clin Psychiatry; 1995 Dec; 56(12):556-9. PubMed ID: 8530331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of clozapine in treatment of psychotic disorder in Parkinson disease].
    Abbar M; Courtet P; Castelnau D
    Encephale; 1996; 22(1):53-63. PubMed ID: 8681876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clozapine in the treatment of mental manifestations of Parkinson disease].
    Diederich N; Keipes M; Graas M; Metz H
    Rev Neurol (Paris); 1995 Apr; 151(4):251-7. PubMed ID: 7481376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine for psychosis in Parkinson's disease.
    Pfeiffer RF; Kang J; Graber B; Hofman R; Wilson J
    Mov Disord; 1990; 5(3):239-42. PubMed ID: 2388641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C; Jankovic J
    Expert Rev Neurother; 2006 Jan; 6(1):7-17. PubMed ID: 16466307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current use of clozapine in Parkinson disease and related disorders.
    Thomas AA; Friedman JH
    Clin Neuropharmacol; 2010; 33(1):14-6. PubMed ID: 20023573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.
    Storch A; Trenkwalder C; Oehlwein C; Winkelmann J; Polzer U; Hundemer HP; Schwarz J
    Parkinsonism Relat Disord; 2005 Sep; 11(6):393-8. PubMed ID: 15993640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus among parkinsonian patients treated chronically with clozapine.
    Fernandez HH; Friedman JH; Lansang MC; Factor SA; Molho ES; Coskun DJ
    Parkinsonism Relat Disord; 2004 Oct; 10(7):439-41. PubMed ID: 15465403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.